-
1دورية أكاديمية
المؤلفون: Ito T; Department of Pharmaceutics, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan., Kubo Y; Laboratory of Drug Disposition & Pharmacokinetics, Faculty of Pharmaceutical Sciences, Teikyo University, Kaga 2-11-1, Tokyo 173-8605, Japan. Electronic address: kubo.yoshiyuki.jf@teikyo-u.ac.jp., Tega Y; Department of Pharmaceutics, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan., Akanuma SI; Department of Pharmaceutics, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan., Hosoya KI; Department of Pharmaceutics, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
المصدر: Journal of pharmaceutical sciences [J Pharm Sci] 2024 Aug; Vol. 113 (8), pp. 2616-2624. Date of Electronic Publication: 2024 Apr 26.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 2985195R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-6017 (Electronic) Linking ISSN: 00223549 NLM ISO Abbreviation: J Pharm Sci Subsets: MEDLINE
مواضيع طبية MeSH: Ribavirin*/metabolism , Ribavirin*/pharmacokinetics , Blood-Testis Barrier*/metabolism , Blood-Testis Barrier*/drug effects , Xenopus laevis* , Antiviral Agents*/pharmacokinetics , Antiviral Agents*/metabolism, Animals ; Male ; Mice ; Biological Transport ; Equilibrative-Nucleoside Transporter 2/metabolism ; Equilibrative-Nucleoside Transporter 2/genetics ; Cell Line ; Sertoli Cells/metabolism ; Sertoli Cells/drug effects ; Oocytes/metabolism ; Oocytes/drug effects ; Testis/metabolism ; Testis/drug effects
-
2دورية أكاديمية
المؤلفون: Paudel KR; Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW 2007, Australia., Singh M; Department of Biotechnology, Jaypee Institute of Information Technology (JIIT), Noida, Uttar Pradesh, India; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW 2007, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW 2007, Australia., De Rubis G; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW 2007, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW 2007, Australia., Kumbhar P; Department of Pharmaceutics, Tatyasaheb Kore College of Pharmacy, Warananagar, Tal: Panhala, Dist: Kolhapur, Maharashtra 416113, India., Mehndiratta S; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW 2007, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW 2007, Australia., Kokkinis S; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW 2007, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW 2007, Australia., El-Sherkawi T; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW 2007, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW 2007, Australia., Gupta G; Centre for Research Impact & Outcome, Chitkara College of Pharmacy, Chitkara University, Rajpura, 140401, Punjab, India; Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates., Singh SK; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW 2007, Australia; School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi GT Road, Phagwara 144411, Punjab, India., Malik MZ; Department of Genetics and Bioinformatics, Dasman Diabetes Institute, Dasman, Kuwait city 15462, Kuwait., Mohammed Y; Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, QLD 4102, Australia., Oliver BG; Woolcock Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia; School of Life Sciences, University of Technology Sydney, Ultimo, NSW 2007, Australia., Disouza J; Department of Pharmaceutics, Tatyasaheb Kore College of Pharmacy, Warananagar, Tal: Panhala, Dist: Kolhapur, Maharashtra 416113, India., Patravale V; Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Nathalal Parekh Marg, Matunga, Mumbai 400019, Maharashtra, India., Hansbro PM; Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW 2007, Australia. Electronic address: philip.hansbro@uts.edu.au., Dua K; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW 2007, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW 2007, Australia. Electronic address: Kamal.Dua@uts.edu.au.
المصدر: Life sciences [Life Sci] 2024 Sep 01; Vol. 352, pp. 122859. Date of Electronic Publication: 2024 Jun 25.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0375521 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0631 (Electronic) Linking ISSN: 00243205 NLM ISO Abbreviation: Life Sci Subsets: MEDLINE
مواضيع طبية MeSH: Drug Repositioning*/methods , Lung Neoplasms*/drug therapy , Lung Neoplasms*/pathology , Ribavirin*/pharmacology , Cell Proliferation*/drug effects , Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/therapeutic use, Humans ; A549 Cells ; Cell Movement/drug effects ; Apoptosis/drug effects ; Molecular Docking Simulation ; Antiviral Agents/pharmacology ; Computational Biology/methods ; Adenocarcinoma of Lung/drug therapy ; Adenocarcinoma of Lung/pathology ; Adenocarcinoma of Lung/genetics ; Adenocarcinoma of Lung/metabolism
-
3دورية أكاديمية
المصدر: Clinical laboratory [Clin Lab] 2024 Aug 01; Vol. 70 (8).
نوع المنشور: Case Reports; Journal Article
بيانات الدورية: Publisher: Clinical Laboratory Publications Country of Publication: Germany NLM ID: 9705611 Publication Model: Print Cited Medium: Internet ISSN: 1433-6510 (Print) Linking ISSN: 14336510 NLM ISO Abbreviation: Clin Lab Subsets: MEDLINE
مواضيع طبية MeSH: Respiratory Syncytial Virus Infections*/diagnosis , Respiratory Syncytial Virus Infections*/complications , Respiratory Syncytial Virus Infections*/drug therapy , Antiviral Agents*/therapeutic use , Antiviral Agents*/administration & dosage , Ribavirin*/therapeutic use , Ribavirin*/administration & dosage, Humans ; Male ; Bronchoalveolar Lavage Fluid/virology ; Immunocompromised Host ; Bronchoscopy ; Adult ; Tomography, X-Ray Computed ; Middle Aged ; Treatment Outcome
-
4دورية أكاديميةDegradation and detoxification of ribavirin by UV/chlorine/Fe(II) process in water treatment system.
المؤلفون: Jiang Y; College of Environmental and Resource Sciences, College of Carbon Neutral Modern Industry, Fujian Normal University, Fuzhou, 350117, Fujian, China., He Z; College of Environmental and Resource Sciences, College of Carbon Neutral Modern Industry, Fujian Normal University, Fuzhou, 350117, Fujian, China., Zhang T; College of Environmental and Resource Sciences, College of Carbon Neutral Modern Industry, Fujian Normal University, Fuzhou, 350117, Fujian, China., Yang J; College of Environmental and Resource Sciences, College of Carbon Neutral Modern Industry, Fujian Normal University, Fuzhou, 350117, Fujian, China., Fan Y; College of Environmental and Resource Sciences, College of Carbon Neutral Modern Industry, Fujian Normal University, Fuzhou, 350117, Fujian, China., Lu Z; College of Environmental and Resource Sciences, College of Carbon Neutral Modern Industry, Fujian Normal University, Fuzhou, 350117, Fujian, China., Cai K; College of Chemistry and Materials Science, Fujian Provincial Key Laboratory of Advanced, Materials Oriented Chemical Engineering, Fujian Normal University, Fuzhou, 350117, China.; Fujian Provincial Key Laboratory of Theoretical and Computational Chemistry, Xiamen, 361005, China., Sun Q; College of Environmental and Resource Sciences, College of Carbon Neutral Modern Industry, Fujian Normal University, Fuzhou, 350117, Fujian, China. minglei_2008@fjnu.edu.cn.; Fujian Key Laboratory of Pollution Control & Resource Reuse, Fuzhou, 350117, Fujian, China. minglei_2008@fjnu.edu.cn., Wang F; College of Environmental and Resource Sciences, College of Carbon Neutral Modern Industry, Fujian Normal University, Fuzhou, 350117, Fujian, China.; Fujian Key Laboratory of Pollution Control & Resource Reuse, Fuzhou, 350117, Fujian, China.
المصدر: Environmental science and pollution research international [Environ Sci Pollut Res Int] 2024 Jul; Vol. 31 (35), pp. 48164-48174. Date of Electronic Publication: 2024 Jul 17.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Springer Country of Publication: Germany NLM ID: 9441769 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1614-7499 (Electronic) Linking ISSN: 09441344 NLM ISO Abbreviation: Environ Sci Pollut Res Int Subsets: MEDLINE
مواضيع طبية MeSH: Water Purification*/methods , Ultraviolet Rays* , Chlorine*/chemistry , Water Pollutants, Chemical*/chemistry , Ribavirin*/chemistry , Iron*/chemistry, Kinetics
-
5دورية أكاديمية
المؤلفون: Zaid AB; Department of Clinical Pathology, National Liver Institute, Menoufia University, Shibin Elkom 32511, Egypt., Almady SK; Department of Hepatology and Gastroenterology, National Liver Institute, Menoufia University, Shibin-Elkom 32511, Egypt., Awad SM; Department of Clinical Microbiology, National Liver Institute, Menoufia University, Shibin Elkom 32511, Egypt., Elabd MG; Department of Clinical Pathology, National Liver Institute, Menoufia University, Shibin Elkom 32511, Egypt., Saied SA; Department of Clinical Pathology, National Liver Institute, Menoufia University, Shibin Elkom 32511, Egypt., Saied AA; Ministry of Tourism and Antiquities, Aswan Office, Aswan 81511, Egypt., Elmalawany AM; Department of Clinical Pathology, National Liver Institute, Menoufia University, Shibin Elkom 32511, Egypt. Electronic address: smalawany@liver.menofia.edu.eg.
المصدر: Current research in translational medicine [Curr Res Transl Med] 2024 Sep; Vol. 72 (3), pp. 103443. Date of Electronic Publication: 2024 Mar 01.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier-Masson SAS Country of Publication: France NLM ID: 101681234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2452-3186 (Electronic) Linking ISSN: 24523186 NLM ISO Abbreviation: Curr Res Transl Med Subsets: MEDLINE
مواضيع طبية MeSH: Carbamates*/therapeutic use , Killer Cells, Natural*/immunology , Killer Cells, Natural*/drug effects , Sofosbuvir*/therapeutic use , Imidazoles*/therapeutic use , Pyrrolidines*/therapeutic use , Ribavirin*/therapeutic use , Valine*/analogs & derivatives , Valine*/therapeutic use , Hepacivirus*/genetics , Hepacivirus*/drug effects , Antiviral Agents*/therapeutic use , Hepatitis C, Chronic*/drug therapy , Drug Therapy, Combination*, Humans ; Male ; Female ; Egypt/epidemiology ; Middle Aged ; Adult ; Treatment Outcome ; Prognosis
-
6دورية أكاديمية
المؤلفون: García-Crespo C; Centro de Biología Molecular Severo Ochoa (CBM), CSIC-UAM, Campus de Cantoblanco, Madrid, Spain., de Ávila AI; Centro de Biología Molecular Severo Ochoa (CBM), CSIC-UAM, Campus de Cantoblanco, Madrid, Spain., Gallego I; Centro de Biología Molecular Severo Ochoa (CBM), CSIC-UAM, Campus de Cantoblanco, Madrid, Spain., Soria ME; Centro de Biología Molecular Severo Ochoa (CBM), CSIC-UAM, Campus de Cantoblanco, Madrid, Spain.; Department of Clinical Microbiology, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain., Durán-Pastor A; Department of Molecular and Cell Biology, Centro Nacional de Biotecnología (CNB-CSIC), Consejo Superior de Investigaciones Científicas (CSIC), Campus de Cantoblanco, Madrid, Spain., Somovilla P; Centro de Biología Molecular Severo Ochoa (CBM), CSIC-UAM, Campus de Cantoblanco, Madrid, Spain.; Departamento de Biología Molecular, Universidad Autónoma de Madrid, Campus de Cantoblanco, Madrid, Spain., Martínez-González B; Department of Clinical Microbiology, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.; Department of Molecular and Cell Biology, Centro Nacional de Biotecnología (CNB-CSIC), Consejo Superior de Investigaciones Científicas (CSIC), Campus de Cantoblanco, Madrid, Spain., Muñoz-Flores J; GMS Management Solutions S.L., Torre Picasso, Madrid, Spain., Mínguez P; Department of Genetics & Genomics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.; Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.; Bioinformatics Unit, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain., Salar-Vidal L; Department of Clinical Microbiology, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.; Centre for Biomedical Network Research on Infectious Diseases (CIBERINFEC), Madrid, Spain., Esteban-Muñoz M; Department of Clinical Microbiology, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain., Cañar-Camacho E; Department of Clinical Microbiology, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain., Ferrer-Orta C; Institut de Biologia Molecular de Barcelona, Consejo Superior de Investigaciones Científicas (IBMB-CSIC), Barcelona, Spain., Zuñiga S; Department of Molecular and Cell Biology, Centro Nacional de Biotecnología (CNB-CSIC), Consejo Superior de Investigaciones Científicas (CSIC), Campus de Cantoblanco, Madrid, Spain., Sola I; Department of Molecular and Cell Biology, Centro Nacional de Biotecnología (CNB-CSIC), Consejo Superior de Investigaciones Científicas (CSIC), Campus de Cantoblanco, Madrid, Spain., Enjuanes L; Department of Molecular and Cell Biology, Centro Nacional de Biotecnología (CNB-CSIC), Consejo Superior de Investigaciones Científicas (CSIC), Campus de Cantoblanco, Madrid, Spain., Esteban J; Department of Clinical Microbiology, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.; Centre for Biomedical Network Research on Infectious Diseases (CIBERINFEC), Madrid, Spain., Fernández-Roblas R; Department of Clinical Microbiology, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.; Centre for Biomedical Network Research on Infectious Diseases (CIBERINFEC), Madrid, Spain., Gadea I; Department of Clinical Microbiology, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.; Centre for Biomedical Network Research on Infectious Diseases (CIBERINFEC), Madrid, Spain., Gómez J; Instituto de Parasitología y Biomedicina 'López-Neyra' (CSIC), Parque Tecnológico Ciencias de la Salud, Armilla, Granada, Spain., Verdaguer N; Institut de Biologia Molecular de Barcelona, Consejo Superior de Investigaciones Científicas (IBMB-CSIC), Barcelona, Spain., Domingo E; Centro de Biología Molecular Severo Ochoa (CBM), CSIC-UAM, Campus de Cantoblanco, Madrid, Spain., Perales C; Department of Clinical Microbiology, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.; Department of Molecular and Cell Biology, Centro Nacional de Biotecnología (CNB-CSIC), Consejo Superior de Investigaciones Científicas (CSIC), Campus de Cantoblanco, Madrid, Spain.
المصدر: British journal of pharmacology [Br J Pharmacol] 2024 Aug; Vol. 181 (15), pp. 2636-2654. Date of Electronic Publication: 2024 Apr 14.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5381 (Electronic) Linking ISSN: 00071188 NLM ISO Abbreviation: Br J Pharmacol Subsets: MEDLINE
مواضيع طبية MeSH: Alanine*/analogs & derivatives , Alanine*/pharmacology , Ribavirin*/pharmacology , Antiviral Agents*/pharmacology , Adenosine Monophosphate*/analogs & derivatives , Adenosine Monophosphate*/pharmacology , Drug Synergism* , SARS-CoV-2*/drug effects, Chlorocebus aethiops ; Vero Cells ; Animals ; Humans ; COVID-19 Drug Treatment ; COVID-19/virology
-
7دورية أكاديمية
المؤلفون: Chen J; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510182, China; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China; Guangzhou Laboratory, Guangzhou, 510005, China. Electronic address: chen_jizheng@gzlab.ac.cn., Qiu P; Jiangsu Province Key Lab of Human Functional Genomics, Department of Biochemistry and Molecular Biology, Nanjing Medical University, Nanjing, 210029, China., Zhao T; Jiangsu Province Key Lab of Human Functional Genomics, Department of Biochemistry and Molecular Biology, Nanjing Medical University, Nanjing, 210029, China., Jiang H; Jiangsu Province Key Lab of Human Functional Genomics, Department of Biochemistry and Molecular Biology, Nanjing Medical University, Nanjing, 210029, China., Tursun K; The First Affiliated Hospital of Xinjiang Medical University, Urumchi, 830054, China., Ksimu S; The First Affiliated Hospital of Xinjiang Medical University, Urumchi, 830054, China., Chen X; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China; Guangzhou Laboratory, Guangzhou, 510005, China. Electronic address: chen_xinwen@gzlab.ac.cn., Wang Q; Jiangsu Province Key Lab of Human Functional Genomics, Department of Biochemistry and Molecular Biology, Nanjing Medical University, Nanjing, 210029, China. Electronic address: wqian@njmu.edu.cn.
المصدر: Virologica Sinica [Virol Sin] 2024 Aug; Vol. 39 (4), pp. 667-674. Date of Electronic Publication: 2024 Jun 29.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier B.V. on behalf of KeAi Communications Co. Ltd Country of Publication: Netherlands NLM ID: 101514185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1995-820X (Electronic) Linking ISSN: 1995820X NLM ISO Abbreviation: Virol Sin Subsets: MEDLINE
مواضيع طبية MeSH: Insulin Resistance* , Antiviral Agents*/therapeutic use , Insulin-Secreting Cells*/drug effects , Insulin-Secreting Cells*/virology , Hepatitis C, Chronic*/drug therapy , Hepatitis C, Chronic*/virology , Hepatitis C, Chronic*/complications , Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/complications , Glucose Tolerance Test* , Ribavirin*/therapeutic use, Humans ; Male ; Female ; Middle Aged ; Adult ; Blood Glucose/analysis ; Sustained Virologic Response ; Aged ; Insulin/therapeutic use ; Prediabetic State/drug therapy ; Prediabetic State/virology
-
8دورية أكاديمية
المؤلفون: Singh P; School of Biotechnology, Jawaharlal Nehru University, New Delhi 110067, India., Akhtar A; School of Biotechnology, Jawaharlal Nehru University, New Delhi 110067, India., Admane N; School of Biotechnology, Jawaharlal Nehru University, New Delhi 110067, India., Grover A; School of Biotechnology, Jawaharlal Nehru University, New Delhi 110067, India. Electronic address: abhinavgr@gmail.com.
المصدر: Computational biology and chemistry [Comput Biol Chem] 2024 Oct; Vol. 112, pp. 108155. Date of Electronic Publication: 2024 Jul 16.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101157394 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-928X (Electronic) Linking ISSN: 14769271 NLM ISO Abbreviation: Comput Biol Chem Subsets: MEDLINE
مواضيع طبية MeSH: alpha-Synuclein*/metabolism , alpha-Synuclein*/antagonists & inhibitors , alpha-Synuclein*/chemistry , Antiviral Agents*/pharmacology , Antiviral Agents*/chemistry , Ribavirin*/pharmacology , Ribavirin*/chemistry , Amyloid*/metabolism , Amyloid*/chemistry , Amyloid*/antagonists & inhibitors , Amyloid*/drug effects, Humans ; Protein Aggregates/drug effects ; Dose-Response Relationship, Drug
-
9دورية أكاديمية
المؤلفون: Sabokrouh A; Department of Biochemistry, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran. sabokrouh22@gmail.com., Hajivand S; Department of Biochemistry and Biophysics, Faculty of Advanced Sciences and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran., Atabi F; Department of Biochemistry and Biophysics, Faculty of Advanced Sciences and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
المصدر: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2024 Jun; Vol. 397 (6), pp. 3907-3915. Date of Electronic Publication: 2023 Nov 17.
نوع المنشور: Journal Article; Comparative Study
بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1912 (Electronic) Linking ISSN: 00281298 NLM ISO Abbreviation: Naunyn Schmiedebergs Arch Pharmacol Subsets: MEDLINE
مواضيع طبية MeSH: Telomerase*/genetics , Telomerase*/metabolism , Ribavirin*/pharmacology , Ribavirin*/therapeutic use , Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/therapeutic use , Proto-Oncogene Proteins c-bcl-2*/genetics , Proto-Oncogene Proteins c-bcl-2*/metabolism, Humans ; Cell Line, Tumor ; Gene Expression Regulation, Neoplastic/drug effects ; Platinum Compounds/pharmacology ; Platinum Compounds/therapeutic use
-
10دورية أكاديمية
المؤلفون: Song X; Department of Blood Transfusion, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China., Xu X; Department of Blood Transfusion, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China., Ren X; Department of Blood Transfusion, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China., Ruan X; Department of Blood Transfusion, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China., Bo J; Department of Blood Transfusion, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.
المصدر: Journal of clinical apheresis [J Clin Apher] 2024 Jun; Vol. 39 (3), pp. e22131.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8216305 Publication Model: Print Cited Medium: Internet ISSN: 1098-1101 (Electronic) Linking ISSN: 07332459 NLM ISO Abbreviation: J Clin Apher Subsets: MEDLINE
مواضيع طبية MeSH: Ribavirin*/therapeutic use , Plasma Exchange*/methods , Critical Illness* , Severe Fever with Thrombocytopenia Syndrome*/therapy , Severe Fever with Thrombocytopenia Syndrome*/drug therapy, Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; Aged ; Antiviral Agents/therapeutic use ; Adult ; Combined Modality Therapy